Curcumin assimilation

[Guest guest]

Here is a important key point above this marketing claims :

PISCATAWAY, N.J., December 19, 2005 - Sabinsa Corporation's Curcumin C3

Complex® was named as the curcumin ingredient of choice by M.D.

Cancer Center at the University of Texas. M.D. Cancer Center is

currently conducting numerous studies to determine the effects of curcumin, an

extract of turmeric root, in fighting against several types of cancers.

" Although there are numerous companies that supply curcumin, consumers need to

be careful that they are buying the genuine product, which is why we recommend

Sabinsa Corporation, " stated Dr. Bharat Aggarwal, professor of cancer research,

M.D. Cancer Center. " A 'supercurcumin' is also available from Sabinsa

that contains Bioperine®, a standardized pepper extract, which enhances

curcumin's effectiveness. "

According to researchers at M.D. Cancer Center, curcumin blocks a key

biological pathway needed for development of melanoma and other cancers.

Curcumin shuts down nuclear factor-kappa B (NF-kB), a powerful master switch

known to regulate expression of more than 300 genes that promote an abnormal

inflammatory response that leads to a variety of disorders, including arthritis

and cancer.

" We strive to provide safe and effective standardized ingredients of the highest

quality to our customers around the world. It is gratifying to see the growing

interest in research involving our patented Curcumin C3 Complex, " stated Todd

Norton, president, Sabinsa Corporation.

Curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin are

collectively known as curcuminoids, and are recognized as one of the most

promising food derived compounds in fighting cancer. Sabinsa Corporation

provides an extract of turmeric standardized to 95 percent curcuminoids,

Curcumin C3 Complex®. Over the past several years, numerous studies have been

funded by the National Institutes of Health to investigate the role of curcumin

and its derivatives in treatment of patients with cancer.

Additionally, M.D. Cancer Center is involved in pre-clinical and

clinical research of the anti-cancer mechanism and application of curcuminoids

in conditions including lung, breast, multiple myeloma, pancreatic,

myelodysplatic syndrome, colon, prostate and head and neck cancers. For more

information visit www.curcuminoids.com.

Moreover I've to add that recent researches pointed that a liposomial form of

curcumin (encapsulated with lecithin) could be really enhancing the

assimilation. We are working on this. I'bve enclosed the research paper